Evidence map›Paper›PMID 38900729›Full record

ArticlePloS one2024

Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon.

Juliette-Laure Ndzie Ondigui, Nadège Mafopa Goumkwa, Cindy Lobe, Brigitte Wandji, Patrick Awoumou, Prisca Voussou Djivida, Puinta Peyonga, Solange Manju Atah, Vivian Verbe, Rachel Kamgaing Simo and 7 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Juliette-Laure Ndzie OndiguiFaculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon.
Nadège Mafopa GoumkwaChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
Cindy LobeChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
Brigitte WandjiYaoundé Gyanecology Obstetrics and Paediatrics Hospital, Yaounde, Cameroon.
Patrick AwoumouChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
Prisca Voussou DjividaFaculty of Medicine and Biomedical Sciences, Department of Biochemistry, University of Yaounde 1, Yaounde, Cameroon.
Puinta PeyongaFaculty of Medicine and Biomedical Sciences, Department of Biochemistry, University of Yaounde 1, Yaounde, Cameroon.
Solange Manju AtahFaculty of Medicine and Biomedical Sciences, Department of Public Health, University of Yaounde 1, Yaounde, Cameroon.
Vivian VerbeCité Verte District Hospital, Yaounde, Cameroon.
Rachel Kamgaing SimoChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
Sylvie Agnès MoudourouChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.
Ana GutierrezBikop Catholic Health Center, Bikop, Cameroon.
Rosi GarciaBikop Catholic Health Center, Bikop, Cameroon.
Isabelle FernandezBikop Catholic Health Center, Bikop, Cameroon.
Sara Honorine Riwom EssamaFaculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon.
Robinson MbuYaoundé Gyanecology Obstetrics and Paediatrics Hospital, Yaounde, Cameroon.
Judith TorimiroChantal BIYA" International Reference Center for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.ORCID 0000-0003-3844-8428

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) and hepatitis delta virus (HDV) co-infection has been described as the most severe form of viral hepatitis, and can be co-transmitted from mother-to-child. A seroprevalence of 4.0% of HDV infection was reported in pregnant women in Yaoundé, and 11.9% in the general population in Cameroon. Our objective was to describe the rate of HDV infection in HBsAg-positive pregnant women and to determine risk factors associated with mother-to-child transmission of HDV. MATERIALS AND

methodsA cross-sectional, descriptive study was conducted from January 2019 to July 2022 among pregnant women attending antenatal contacts in seven health structures in the Centre Region of Cameroon. A consecutive sampling (non-probability sampling) was used to select only pregnant women of age over 21 years, who gave a written informed consent. Following an informed consent, an open-ended questionnaire was used for a Knowledge, Attitude and Practice (KAP) survey of these women, and their blood specimens collected and screened for HBsAg, anti-HIV and anti-HCV antibodies by rapid tests and ELISA. HBsAg-positive samples were further screened for HBeAg, anti-HDV, anti-HBs, and anti HBc antibodies by ELISA, and plasma HDV RNA load measured by RT-qPCR.

resultsOf 1992 pregnant women, a rate of 6.7% of HBsAg (133/1992) with highest rate in the rural areas, and 3.9% of hepatitis vaccination rate were recorded. Of 130, 42 (32.3%) were anti-HDV antibody-positive, and 47.6% had detectable HDV RNA viraemia. Of 44 anti-HDV-positive cases, 2 (4.5%) were co-infected with HBV and HCV, while 5 (11.4%) with HIV and HBV. Multiple pregnancies, the presence of tattoos and/or scarifications were significantly associated with the presence of anti-HDV antibodies. Of note, 80% of women with negative HBeAg and positive anti-HBe serological profile, had plasma HDV RNA load of more than log 3.25 (>10.000 copies/ml).

conclusionThese results show an intermediate rate of HDV infection among pregnant women with high level of HDV RNA viremia, which suggest an increased risk of vertical and horizontal co-transmission of HDV.

Indexed as

Hepatitis DHepatitis Delta VirusInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultCameroonCoinfectionCross-Sectional StudiesFemaleHepatitis BHepatitis B Surface AntigensHumansPregnancyPrevalenceRisk FactorsSeroepidemiologic StudiesHepatitis B Surface Antigens

Identifiers

PMID38900729
PMCPMC11189217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.